![Gels | Free Full-Text | Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System Gels | Free Full-Text | Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System](https://www.mdpi.com/gels/gels-08-00082/article_deploy/html/images/gels-08-00082-g001.png)
Gels | Free Full-Text | Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System
![PDF] Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting. | Semantic Scholar PDF] Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/08e146b256142472fd3f2f1690b7139941d1caad/4-Figure2-1.png)
PDF] Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting. | Semantic Scholar
![Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/Recombinant%20Albumin%20Alpha%20and%20Prime_thumb.jpg)
Recombinant human albumin from Novozymes Biopharma helps innovative dry eye therapy move into clinical trials
![PDF) Human Albumin Eye Drops as a Therapeutic Option for the Mmanagement of Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease after Stem-Cell Allografting PDF) Human Albumin Eye Drops as a Therapeutic Option for the Mmanagement of Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease after Stem-Cell Allografting](https://i1.rgstatic.net/publication/283594278_Human_Albumin_Eye_Drops_as_a_Therapeutic_Option_for_the_Mmanagement_of_Keratoconjunctivitis_Sicca_Secondary_to_Chronic_Graft-Versus-Host_Disease_after_Stem-Cell_Allografting/links/56b36f7508ae156bc5fb284f/largepreview.png)